Cigarette smoking and large cell carcinoma of the lung by Muscat, Joshua E. et al.
Vol. 6, 477-480, July 1997 Cancer Epidemiology, Biomarkers & Prevention 477
Cigarette Smoking and Large Cell Carcinoma of the Lung1
Joshua E. Muscat,2 Steven D. Steilman, Zuo-Feng Zhang,
Alfred I. Neugut, and Ernst L. Wynder
Division of Epidemiology, American Health Foundation, New York, New
York 10017 [J. E. M., S. D. S., E. L. W.J; Department of Epidemiology,
Memorial Hospital, New York, New York 10021 [Z-F. Z.]; and School of
Public Health, Columbia University, New York, New York 10032 [A. I. N.]
Abstract
Large cell carcinoma is the fourth most common
histological type of lung cancer in the United States.
Cigarette smoking causes large cell lung cancer, but it is
uncertain whether the effect varies with the amount and
duration of smoking. This uncertainty stems from
ambiguity in the histopathological classification of large
cell cancer, especially before 1971, and the relatively
infrequent occurrence of large cell cancer in
epidemiological studies. The present case-control
investigation demonstrates that the risk of large cell
cancer increases with both the frequency and number of
years of cigarette smoking. The odds ratio associated with
smoking two or more packs/day was 37.0 (95%
confidence interval, 16.4-83.2) in men and 72.9 (35.4-
150.2) in women. It is concluded that cigarette smoking is
the predominant cause of large cell lung cancer.
Introduction
Cigarette smoking has been conclusively established as the
major cause of lung cancer. The dose of smoking is strongly
related to an increasing risk of epidermoid (squamous) adeno-
carcinoma and small cell lung cancers (1, 2), which comprise
70% of lung cancers in the SEER3 program (3; Table 1). The
fourth most common lung cancer cell type is large cell carci-
noma, comprising about 9% oflung tumors. Although large cell
cancer causes approximately 15,000 deaths per year (4) in the
United States, the effect of cigarette dose has not been estab-
lished. In fact, based on the results of an ongoing case-control
study conducted by our group, the risk of large cell cancer did
not increase with the number of CPD (2). This observation was
noted for data analyzed between 1985 and 1990. The lack of a
dose-response trend seems inconsistent with the known carci-
nogenic effects of tobacco smoke. We, therefore, reexamined
this relationship using a larger sample size.
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Materials and Methods
The study methodology is described in detail elsewhere (2). To
summarize, data from an on-going multicenter case-control
study of smoking and lung cancer was analyzed for the time
period 1980-1995 (see “Acknowledgments”). Hospitalized pa-
tients with newly diagnosed bronchogenic cancer were ap-
proached and requested to participate in an interview using a
structured questionnaire. The histological type of lung cancer
was determined by review of the patient’s pathology report.
Eligible controls were patients admitted to the hospital for
conditions unrelated to tobacco exposure. Controls were se-
lected from the daily admission rosters and frequency matched
to cases on the basis of sex, age (±5 years), hospital, and year
of interview. Among the 2545 male controls, 49.7% had cancer
(predominantly colorectal, prostate, stomach, skin, lymphoma,
and leukemia); 6% had benign growths including benign pros-
tatic hypertrophy; 37.7% had nonmalignant disease; and 6.6%
had fractures or injuries. Among the 1715 female controls, the
diagnosis was cancer in 49.7% (predominantly breast, colorec-
tat, and ovarian); 15.4%, benign growths; 11.3%, injuries/frac-
tures; and 23.6%, other nonmalignant conditions. Each partic-
ipant signed a consent form that had been approved by the
hospital’s Institutional Review Board.
For the current analysis, we compared the subset of pa-
tients with large cell carcinoma to the entire lung cancer control
series. For OR calculations, the effects of smoking were ad-
justed for age at diagnosis (four categories) and years of edu-
cation (four categories) using nonsmokers as the referent cat-
egory in logistic regression analyses. Trend tests were
calculated for the number of cigarettes smoked per day and the
number of years smoking by categorizing these variables and
assigning median values to these categories. To determine the
effect of the type of cigarette (lifetime filter smoker versus
lifetime nonfilter smoker versus smoker of both types) on large
cell cancer risk, the analysis was conducted among ever-smok-
ers with nonfilter smokers serving as the reference group.
Results
There were 228 men and 154 women diagnosed with large cell
carcinoma during the study period. These patients were corn-
pared to the control series of 2545 men and 1715 women. The
ages, educational levels, and races are presented in Table 2.
Ninety-three % of cases and 92% of controls were white. The
mean years of education were 13. 1 in male cases versus 13.6 in
male controls (P < 0.01) and 12.8 in female cases versus 13.2
in female controls (P < 0.01). Cases began smoking cigarettes
earlier than controls. The mean age of smoking onset in men
was 16.9 in cases versus 17.9 in controls (P < 0.01). In women,
the mean age of smoking onset was 18.9 in cases versus 20.4 in
controls (P < 0.01).
The risk of large cell cancer increased substantially with
the number of cigarettes smoked in current smokers and former
smokers (Table 3). The adjusted OR for current smokers of
40 CPD was 37.0 (95% CI, 16.4-83.2) in men and 72.9(95%
CI interval, 35.4-150.2) in women. The risk of cancer was also
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Table 1 Distribution of histological ty pes of lung cancer
SEER, 1983-1987#{176} AHF, 1985-1990”
Histology
Males Females Males Females
Squamous cell 31.2 19.0 32.8 19.5
Small cell 16.6 20.2 10.6 11.7
Large cell 9.3 8.9 10.2 10.4
Adenocarcinoma 22.7 29.7 36.4 45.4
Bronchioalveolar 2.5 4.6 1.9 4.7
Other 16.7 17.6 8.1 8.3
a SEER program, 1983-1987 based on 39,653 male lung cancers and 20,867
female lung cancers.
b Ajj American Health Foundation case-control data of 1,165 male lung cases
and 750 female lung cases.
highly dependent on the number ofyears of smoking (Table 3). In
ex-srnokers, the risk decreased with the number of years since
quitting (TaMe 3). Most smokers had smoked both filter and
nonfilter cigarettes over their lifetimes. There were too few men
and women who smoked exclusively nonfilter or filter cigarettes to
examine the effects of cigarette type with precision.
Discussion
It is established that the likelihood of contracting lung cancer
increases with the frequency and duration of cigarette smoking.
In former cigarette smokers, the risk decreases substantially
with the number of years since quitting. The present study
demonstrates the same associations between cigarette smoking
and large cell lung cancer. No association was found with cigar
smoking. When comparing the association between smoking
and large cell cancer with the other major histological types of
lung cancer in this data during the same study period (1980-
1995), the OR for current cigarette smokers (18.0 in men and
20.2 in women; Table 3) was intermediate between the OR for
squamous cell carcinoma (56.6 in men and 37. 1 in women) and
adenocarcinoma (10.2 in men and 12.7 in women).
Several possible biases should be considered when inter-
preting these findings. In case-control studies, the smoking
rates in the hospital control population may exceed that in the
community. To address this issue, a randomly selected sample
of age-matched neighborhood controls were interviewed in
1980 and 1981 (5). The data showed a slightly greater smoking
rate in the community than in the hospital control group that
was interviewed during 1980 and 1981, suggesting that the
selection of hospital subjects for the control group did not
introduce bias. Another concern is that the data collection
protocols and procedures varied over the long study interval
and that changes in hospital referral patterns may have affected
the risk calculations. The study procedures did remain uniform
throughout the course of the investigation, and all subjects were
interviewed at bedside using the same structured questionnaire.
No changes were made in field supervision staff and interview-
ing instructions and techniques. When the data were analyzed
by three separate time periods (1980-1985, 1986-1990, and
1990-1995), there appeared to be relatively little variability in
the distribution of smoking habits. For example, the percentage
of nonsmoking cases was 2.8, 3.9, and 0% in men and 10, 6.2,
and 10% in women, respectively. Similarly, there were no gross
differences in smoking patterns of subjects between hospitals.
The causes of large cell lung cancer has not been exten-
sively studied for several reasons. Large cell lung cancer is
often a poorly differentiated tumor and was ill-defined in the
1967 WHO classification. Several morphological features of
large cell cancer are shared with other lung cell types. Cam-
pobasso et a!. (6) calculated an interobserver reliability kappa
value of 0.7 1 for large cell lung carcinoma in an archived series
of slides using the 1967 classification. When using the 1981
WHO classification that uses stricter classification criteria, the
number of discrepant values was reduced by 33%. In the SEER
Program, large cell carcinoma was not categorized before 1978.
The reliability of the histological classification in the current
study was not evaluated, although current efforts are under way to
review a sample of slides representing all lung histological types.
It is unlikely that there was extensive misclassification oflarge cell
cancer in this series. Table 1 shows that the histological distribu-
tion of lung cancer in the overall case-control study is similar to
that reported in the SEER system (Table 1). The epidemiology of
large cell cancer has also been hindered became of the relatively
few number of incident cases compared to other lung histological
types. The few studies that examined the rates oflarge cell cancer
by amount of cigarette smoking were inconclusive because of
small sample sizes (7). One case-control study in Japan by Sobue
et a!. (8), which included 81 large cell lung cancer patients, did
show evidence of a dose-response effect. Compared with subjects
who smoked 1-29 years, the OR for large cell cancer was 1.3 for
30-39 years of smoking, 2.1 for 40-49 years of smoking, and 1.6
for 50+ years of smoking. In our previous report that included 97
men and 59 women with large cell lung cancer for the study period
1985-1990 (2), the OR of lung cancer associated with 20 CPD
was calculated among current smokers using 1-19 CPD as the
male and female referent groups, respectively. There were only
three male cases and six female cases in these referent groups; this
appears to have resulted in unstable relative risk estimates.
It is uncertain what carcinogenic agents in tobacco smoke
cause large cell lung cancer. Experimental studies have not
produced large cell carcinoma in the lungs of laboratory mice
and rats (9). Autopsy studies by Auerbach and Garfinkel (10)
show that large cell carcinomas are evenly distributed through-
out the lung, in contrast to squamous cell cancers that arise
primarily in the central lung bronchi and adenocarcinomas that
occur almost exclusively in the peripheral lung. Experimental
animal studies show that the most likely mechanisms of lung
cancer induction in humans differ by the location of the tumor.
The deposition of cigarette particulates containing polycyclic
hydrocarbons in the major lung bronchi probably initiates the
development of squamous cell carcinoma. The tobacco-specific
nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-1-butanone is
a blood-borne carcinogen that is metabolized in the liver and
induces lung adenocarcinoma in highly vascularized, peripheral
lung tissue in animals and possibly humans. It may be that both
particulate deposition and 4-(methylnitrosamino)-l-(3-pyri-
dyl)-l-butanone cause large cell cancer in humans.
An important public health concern is whether the “tar”
content of cigarettes is related to the risk of large cell cancer.
Studies have shown that the risk of lung cancer is lower in
smokers of low tar filter cigarettes relative to smokers of the
higher tar nonfilter cigarettes (1 1-13). Other studies have not
shown this effect (14-16), however, and it has been suggested
that the level of tar in cigarette smoke may be an important
determinant of lung cancer only for some histological types
(17). Our data confirm this hypothesis, showing a reduced risk
of squamous cell carcinoma with filter cigarettes but no reduc-
tion for adenocarcinoma (18). Larger-scale studies are needed
to determine whether the risks for large cell carcinoma vary
between smokers of nonfilter and filter cigarettes.
The role of other possible risk factors for large cell cancer
including air pollution (19, 20) should be explored. In a study
of 755 lung cancer case-control pairs in Trieste, Italy, Barbone
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Table 2 Age, education, and race in cases and controls, 1980-1995
Variable
Men Women
Cases Controls Cases Controls
N = 228% N = 2545% N = 154% N = 1715%
Age
<45 12 5.3 198 7.8 19 123 150 8.8
55-64 47 20.6 435 17.1 33 21.4 366 21.3
65-74 89 39.0 995 39.1 55 35.7 582 33.9
>74 80 35.1 917 36.0 47 30.5 617 36.0
Education
<12 72 31.6 555 21.8 34 22.1 296 17.3
12 69 30.3 669 26.3 68 44.2 636 37.1
13-15 33 14.5 434 17.1 27 17.5 364 21.2
>15 54 23.7 887 34.9 25 16.2 419 24.4
Race
White 212 93.0 2332 91.6 144 93.5 1588 92.6
Black 14 6.1 205 8.1 9 5.8 124 7.3
Other 2 0.9 8 0.3 1 0.7 3 0.2
Table 3 Odds ratio for cigarette smoking and large cell cancer of the lung, 1980-95
Smoking category
Men Women
Cases Controls a Cases Controls




Never 7 650 1 .0 13 936 1.0
Former 99 1113 7.9 3.7-17.2 41 431 7.2 3.8-13.5
Current 120 593 18.0 8.3-39.0 100 348 20.2 11.1-36.7
Cigar/Pipe 2 189 0.9 0.2-4.6 0 0
CPD in current smokers
0 7 650 1.0 13 936 1.0
1-19 16 173 8.3 3.4-20.6 11 130 6.0 2.6-13.7
20-39 45 275 14.6 6.4-33.1 50 177 21.0 11.0-40.1
40 59 144 37.0 16.4-83.2 39 41 72.9 35.4-150.2
Trend P<0.0l P<0.01
CPD in ex-smokers
0 7 650 1.0 13 936 1.0
1-19 16 291 4.8 2.0-11.9 11 199 4.2 1.9-9.6
20-39 41 490 7.4 3.3-16.9 19 154 9.9 4.8-20.7
40 42 331 1 1.1 4.9-25.0 1 1 77 10.5 4.5-24.4
Trend P < 0.01 P < 0.01
Years of smoking
0 7 650 1.0 13 936 1.0
1-19 14 415 2.9 1.2-7.3 9 197 2.9 1.2-6.9
20-39 98 820 10.6 4.9-22.9 74 414 11.5 6.3-21.1
a40 107 470 23.1 10.4-50.8 58 167 30.1 15.8-57.4
Trend P < 0.01 P < 0.01
Years since quitting
0 7 650 1.0 13 936 1.0
>10 56 803 6.1 2.8-13.6 16 287 4.2 2.0-9.0
6-10 20 144 12.9 5.3-31.1 11 74 11.5 5.0-26.7
1-5 23 163 12.4 5.2-29.6 14 69 15.9 7.1-35.4
Trend P < 0.01 P < 0.01
a Adjusted for age and education by logistic regression. Reference group is never smokers for all calculations.
et a!. (20) found increased risks oflarge cell for residents living Acknowledgments
near iron foundries, incinerators, and shipyards. Poor nutrition
may contribute to large cell lung cancer. Steinmetz et a!. (21)
found suggestive evidence that low consumption of vegetables
and fruits was related to an increased risk in a cohort of women
living in Iowa. These fmdings provide further leads in the
epidemiology of large cell lung cancer.
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